Raymond James Upgrades Incyte (INCY) to Outperform
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Raymond James upgraded Incyte (NASDAQ: INCY) from Market Perform to Outperform with a price target of $115.00.
Shares of Incyte closed at $93.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY): Novartis Data Bodes Well For Incyte - RBC
- UPDATE: Stifel Upgrades Legacy Reserves (LGCY) to Hold
- BTIG Upgrades Neogenomics (NEO) to Buy
Create E-mail Alert Related CategoriesUpgrades
Related EntitiesRaymond James
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!